Doctors Note Logo

Published on: 10/14/2026

Is berberine bad for your kidneys? What is known

Berberine is not known to be directly toxic to healthy kidneys, and some research suggests it may actually support kidney function in people with diabetes or metabolic conditions, though human evidence remains limited. However, caution matters for anyone with reduced kidney function, since berberine can interact with medications processed by the liver and kidneys, including metformin, blood pressure drugs, and cyclosporine, potentially raising drug levels. Reported side effects are usually digestive, but dosage, supplement purity, pregnancy, and existing chronic kidney disease all change the safety picture, and several important details are outlined below.

If you are noticing changes like swelling, fatigue, foamy urine, or shifts in how often you urinate, it is worth getting clarity rather than guessing whether a supplement is the cause. A free, instant, online symptom check can help you sort out which symptoms point toward kidney involvement, which may stem from medications or supplements, and what questions to bring to your doctor next.

Last reviewed for medical accuracy: 10/13/2026

answer background

Concerned about your symptoms?

Explanation

Is Berberine Bad for Kidneys? What Science Tells Us

Berberine is a natural compound found in plants like goldenseal, barberry and Oregon grape. It’s become popular as a supplement for blood sugar control, cholesterol management and gut health. But if you’re worried about kidney safety, you’re not alone. This article reviews credible research to answer the question: is berberine bad for kidneys?

What Is Berberine and How Is It Metabolized?

Berberine is an isoquinoline alkaloid with a long history in traditional medicine. Modern studies show it may:

  • Improve insulin sensitivity
  • Lower blood sugar and HbA1c
  • Reduce LDL (“bad”) cholesterol
  • Have anti-inflammatory and antimicrobial effects

Once ingested, berberine is:

  • Poorly absorbed in the gut (bioavailability ~1–5%)
  • Metabolized in the liver via CYP enzymes
  • Mainly excreted in bile; only a small fraction leaves via urine

Because only tiny amounts reach the kidneys, direct kidney toxicity from berberine itself is considered unlikely in healthy people at typical doses (500–1,500 mg/day).

What Clinical Studies Say About Kidneys

Most human trials of berberine focus on metabolic outcomes, but kidney function is often monitored as part of safety assessments. Here’s a quick summary:

• In people with type 2 diabetes, adding 500 mg berberine three times daily for 3 months produced no significant changes in serum creatinine or eGFR.
• A small trial in people with non-alcoholic fatty liver disease (NAFLD) showed stable kidney markers over 16 weeks of berberine 0.5–1 g/day.
• Animal studies in diabetic rats suggest berberine may protect against diabetic nephropathy by reducing oxidative stress and inflammation in kidney tissue.

Overall, clinical data do not show clear evidence that berberine harms kidneys when taken at recommended doses for up to six months.

Rare Case Reports of Kidney-Related Issues

Case reports can highlight unusual but serious events. A few isolated reports link berberine to:

  • Acute kidney injury (AKI) following severe gastrointestinal upset and dehydration
  • Rhabdomyolysis (muscle breakdown) in combination with other supplements or statins, leading to secondary kidney stress

Key points:

  • Dehydration from vomiting or diarrhea can strain kidneys.
  • Combining berberine with other drugs that affect muscle (e.g., statins) might raise rhabdomyolysis risk.

These are very rare and usually involve other risk factors. Keeping well hydrated and avoiding risky drug combinations can minimize concerns.

Potential Interactions and Indirect Kidney Risks

Berberine interacts with several enzymes and transporters:

  • Inhibits P-glycoprotein (P-gp), which can affect drug clearance
  • Modulates CYP3A4 and other CYP enzymes

Drugs that rely on P-gp or CYP3A4—like certain immunosuppressants (e.g., cyclosporine), anticoagulants (e.g., rivaroxaban) or some antibiotics—may accumulate to higher levels if taken with berberine. This could indirectly stress the kidneys or other organs.

Who’s most at risk?

  • People on multiple prescription medications
  • Those with existing chronic kidney disease (CKD) or unstable kidney function
  • Individuals prone to dehydration (e.g., athletes training in heat)

Benefits of Berberine for Kidney Health

Some preclinical studies hint at kidney-protective effects:

  • Antioxidant action: berberine reduces oxidative damage in kidney cells.
  • Anti-inflammatory effects: it may lower kidney inflammation in diabetic models.
  • Fibrosis prevention: berberine could limit scarring in chronic kidney disease.

These findings are promising but need confirmation in larger human trials before recommending berberine as a kidney therapy.

Safe Usage Tips

To minimize any kidney concerns when using berberine, consider:

• Sticking to recommended doses (500–1,500 mg/day in divided doses)
• Taking with food to reduce GI upset and risk of dehydration
• Staying well hydrated throughout the day
• Checking kidney function (e.g., serum creatinine, eGFR) if you have CKD or take multiple meds
• Avoiding simultaneous use with known nephrotoxic drugs unless supervised by your doctor

Signs You Should Pause and Check In

If you experience any of these symptoms while on berberine, it’s wise to get a quick assessment:

  • Reduced urine output or dark urine
  • Unusual fatigue or swelling in legs/feet
  • Severe muscle aches or weakness
  • Persistent nausea, vomiting or diarrhea

You can do a free, online symptom check, using the doctor approved Ubie Symptom Checker to see if you need prompt medical attention.

Who Should Be Extra Careful

• People with chronic kidney disease (CKD) stages 3–5
• Individuals on multiple medications that affect kidney clearance
• Pregnant or breastfeeding women (not enough safety data)
• Children (use in pediatrics is not well studied)

If you fall into one of these groups, discuss berberine use with your healthcare provider. They may recommend periodic blood tests to monitor kidney and liver function.

Bottom Line: Is Berberine Bad for Kidneys?

Based on current evidence:

  • Healthy adults taking usual doses (≤1,500 mg/day) generally show no signs of kidney harm in clinical trials.
  • Preclinical data even suggest potential kidney-protective effects, though human confirmation is needed.
  • Rare case reports link berberine to kidney issues mainly through dehydration or drug interactions.

Berberine is unlikely to be bad for kidneys in most healthy people. However, if you have existing kidney disease, take other drugs that stress kidneys, or experience worrying symptoms, you should act with caution.

Final Recommendations

  1. Speak with your doctor before starting berberine—especially if you have kidney problems or take prescription medications.
  2. Monitor kidney function periodically if you’re at higher risk.
  3. Stay hydrated and follow dosing guidelines.
  4. Use tools like the free, online symptom check, using the doctor approved Ubie Symptom Checker for non-urgent evaluations.
  5. If you notice signs of kidney distress (low urine output, swelling, severe muscle pain), seek medical advice right away.

Nothing in this article replaces professional medical advice. If you experience life-threatening or serious symptoms, please speak to a doctor immediately.

(References)

  • * Yin J, Xing H, Ye J. Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism. 2008 May;57(5):712-7. doi: 10.1016/j.metabol.2008.01.013. PMID: 18442638; PMCID: PMC2410097.

  • * Chronic Kidney Disease: The Gut-Kidney Connection? Integr Med (Encinitas). 2017 Apr;16(2):14-16. PMID: 30881232; PMCID: PMC6413637.

  • * Qin X, Zhao Y, Gong J, Huang W, Su H, Yuan F, Fang K, Wang D, Li J, Zou X, Xu L, Dong H, Lu F. Berberine Protects Glomerular Podocytes via Inhibiting Drp1-Mediated Mitochondrial Fission and Dysfunction. Theranostics. 2019;9(6):1698-1713. doi: 10.7150/thno.30640. Epub 2019 Feb 28. PMID: 31037132; PMCID: PMC6485199.

  • * Rondanelli M, Riva A, Petrangolini G, Allegrini P, Giacosa A, Fazia T, Bernardinelli L, Gasparri C, Peroni G, Perna S. Berberine Phospholipid Is an Effective Insulin Sensitizer and Improves Metabolic and Hormonal Disorders in Women with Polycystic Ovary Syndrome: A One-Group Pretest-Post-Test Explanatory Study. Nutrients. 2021 Oct 19;13(10). doi: 10.3390/nu13103665. Epub 2021 Oct 19. PMID: 34684666; PMCID: PMC8538182.

  • * Liu Y, Gong S, Li K, Wu G, Zheng X, Zheng J, Lu X, Zhang L, Li J, Su Z, Liu Y, Xie J, Chen J, Li Y. Coptisine protects against hyperuricemic nephropathy through alleviating inflammation, oxidative stress and mitochondrial apoptosis via PI3K/Akt signaling pathway. Biomed Pharmacother. 2022 Dec;156:113941. doi: 10.1016/j.biopha.2022.113941. Epub 2022 Nov 2. PMID: 36411660.

  • * Song L, Zhang W, Tang SY, Luo SM, Xiong PY, Liu JY, Hu HC, Chen YQ, Jia B, Yan QH, Tang SQ, Huang W. Natural products in traditional Chinese medicine: molecular mechanisms and therapeutic targets of renal fibrosis and state-of-the-art drug delivery systems. Biomed Pharmacother. 2024 Jan;170:116039. doi: 10.1016/j.biopha.2023.116039. Epub 2023 Dec 28. PMID: 38157643.

  • * Gao R, Lu Y, Zhang W, Zhang Z. The Application of Berberine in Fibrosis and the Related Diseases. Am J Chin Med. 2024;52(3):753-773. doi: 10.1142/S0192415X24500307. Epub 2024 May 8. PMID: 38716621.

  • * Wu J, Li K, Zhou M, Gao H, Wang W, Xiao W. Natural compounds improve diabetic nephropathy by regulating the TLR4 signaling pathway. J Pharm Anal. 2024 Aug;14(8):100946. doi: 10.1016/j.jpha.2024.01.014. Epub 2024 Feb 6. PMID: 39258172; PMCID: PMC11386058.

  • * Wen S, Fu A, Liu F, You Y, Li L, Xiao W, Zhong H, Hong X, Zhong X, Hu Y, Liu Z. Identifying potential drugs for treating Cardiovascular-kidney metabolic syndrome via reverse network pharmacology. Front Pharmacol. 2025;16:1627236. doi: 10.3389/fphar.2025.1627236. Epub 2025 Jun 30. PMID: 40661082; PMCID: PMC12256536.

  • * Zhou W, Asif A, Situ C, Wang J, Hao H. Multiple target and regulatory pathways of berberine. Phytomedicine. 2025 Oct;146:157030. doi: 10.1016/j.phymed.2025.157030. Epub 2025 Jul 11. PMID: 40763599.

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.